Health and safety issues pertaining to genetically modified foods

被引:8
作者
Goodyear-Smith, F [1 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Div Gen Practice & Primary Hlth Care, Auckland 1, New Zealand
关键词
D O I
10.1111/j.1467-842X.2001.tb00597.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Genetic modification involves the insertion of genes from other organisms (within or between species) into host cells to select for desirable qualities. Potential benefits of GM foods include increased nutritional value; reduced allergenicity; pest and disease-resistance; and enhanced processing value. Possible detrimental outcomes include producing foods with novel toxins, allergens or reduced nutritional value, and development of antibiotic resistance or herbicide-resistant weeds. Benefits to individuals or populations need to be weighed against adverse health and environmental risks, and may differ between developing and Westernised countries. Whether testing and monitoring should exceed requirements for conventional foods is under debate. While not necessarily scientifically justifiable, consumer concerns have resulted in Australian and New Zealand requirements to label foods containing GM-produced proteins. Dissatisfied consumer advocacy groups are calling for all foods involving GM technology to be labelled, irrelevant of whether the final product contains novel protein. Goals to improve the quantity, quality and safety of foods are laudable; however, the primary aim of the bio-food industry is financial gain. GM foods may be as safe as conventional foods but public distrust runs high. It is important that discussion is informed by science and that claims of both benefits and risks are evidence-based, to ensure that the process is driven neither by the vested interest of the bio-technical multinational companies on the one hand, nor ill-informed public fears on the other.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 47 条
[1]  
*ADV COMM NOV FOOD, 1994, US ANT RES MARK GEN
[2]  
[Anonymous], 1999, LANCET, V353, P1811
[3]   Stability of food allergens to digestion in vitro [J].
Astwood, JD ;
Leach, JN ;
Fuchs, RL .
NATURE BIOTECHNOLOGY, 1996, 14 (10) :1269-1273
[4]  
*AUSTR NZ FOOD AUT, 2001, GEN MOD FOODS
[5]  
*AUSTR NZ FOOD AUT, 2000, ANZFA OCC PAP SER, V1
[6]   AN INVESTIGATION OF THE CAUSE OF THE EOSINOPHILIA-MYALGIA SYNDROME ASSOCIATED WITH TRYPTOPHAN USE [J].
BELONGIA, EA ;
HEDBERG, CW ;
GLEICH, GJ ;
WHITE, KE ;
MAYENO, AN ;
LOEGERING, DA ;
DUNNETTE, SL ;
PIRIE, PL ;
MACDONALD, KL ;
OSTERHOLM, MT .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (06) :357-365
[7]   DERMATITIS IN GROCERY WORKERS ASSOCIATED WITH HIGH NATURAL CONCENTRATIONS OF FURANOCOUMARINS IN CELERY [J].
BERKLEY, SF ;
HIGHTOWER, AW ;
BEIER, RC ;
FLEMING, DW ;
BROKOPP, CD ;
IVIE, GW ;
BROOME, CV .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (03) :351-355
[8]  
British Medical Association, 1999, IMP GEN MOD AGR FOOD
[9]  
Burke D, 1998, BRIT MED J, V316, P1845
[10]   EBT, a tryptophan contaminant associated with eosinophilia myalgia syndrome, is incorporated into proteins during translation as an amino acid analog [J].
Buss, WC ;
Stepanek, J ;
Bankhurst, AD ;
Mayeno, AN ;
Pastuszyn, A ;
Peabody, D .
AUTOIMMUNITY, 1996, 25 (01) :33-45